Reckitt Partners with Public Health Foundation of India (PHFI) to Drive Transformative Public Health Interventions
New Delhi, Delhi, India: Reckitt, a leading global consumer health and hygiene company, has partnered with the Public Health Foundation of India (PHFI) to strengthen its purpose-led programs across India, with a focus on health, hygiene, sanitation, and life skills education.
Established in 2006, PHFI is a globally recognized public-private initiative that has contributed significantly to building India's public health capacity through education, research, and advocacy. The institution was recently ranked second among schools of public health globally (International Journal of Public Health, March 2024) and has been recognized as an ICMR Collaborating Centre of Excellence.
The partnership brings together Reckitt's deep experience in driving large-scale behavioural change and PHFI's leadership in public health research, education, and policy. Together, the two organizations aim to co-create innovative solutions, strengthen institutional capacity, and document scalable community health models that can be replicated across India.
As part of the collaboration, PHFI will work closely with Reckitt and its civil society partners to validate and document existing outreach programs nationwide. The resulting evidence will be translated into case studies and academic publications to highlight effective, scalable models for health impact.
On the partnership, Professor Sanjay Zodpey, President, Public Health Foundation of India (PHFI), said, 'Partnership between Reckitt and Public Health Foundation of India will develop initiatives responding to community health needs for capacity building, training programs and research to address the public health challenges with a focus on sanitation and hygiene.'
Ravi Bhatnagar, Director, External Affairs and Partnerships, Reckitt – South Asia, said, 'At Reckitt, we believe we achieve more together as trusted partners. Through collaboration, we can collectively drive systemic, long-term positive change. We deeply value this collaboration, which unites PHFI's academic and policy leadership with Reckitt's on-ground experience in driving behavioural change. Hygiene is the foundation of good health, and this partnership marks another meaningful step in our journey to support the vision of Viksit Bharat by 2047. Trusted, purpose-aligned partnerships like this are essential to building a healthier, more resilient India.'
PHFI has established five Indian Institutes of Public Health and contributed more than 4,800 research publications to the field. Its recognition as a global public health leader further showcases the strength it brings to this collaboration to deliver evidence-based health interventions.
With this partnership, Reckitt and PHFI are not only setting a new benchmark for public-private collaboration but also laying the groundwork for transformative change in how India addresses its most pressing health challenges. Grounding interventions in science and scaling them through community action, the partnership aims to deliver lasting improvements in sanitation, hygiene, and public health outcomes. More than a partnership, this is a mission-driven alliance focused on shifting narratives, empowering communities, and reinforcing the foundations of India's public health system. Together, Reckitt and PHFI aim to ensure that access to health and hygiene is a right for all, not a privilege.
About Reckitt
Advertisement
Reckitt* exists to protect, heal and nurture in the pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege. Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.
Every day, around 30 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always. We are a diverse global team of 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more or get in touch with us at www.reckitt.com.
*Reckitt is the trading name of the Reckitt Benckiser group of companies.
Click here for Media Contact Details
Submit your press release
Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Reckitt Benckiser Group PLC (OTC: RBGLY)
NEW YORK--(BUSINESS WIRE)-- Scott+Scott Attorneys at Law LLP ('Scott+Scott'), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Southern District of New York against Reckitt Benckiser Group PLC ('Reckitt' or the 'Company') (OTC: RBGLY), and certain of its former and current officers and/or directors (collectively, 'Defendants'). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (15 U.S.C. §§78j(b) and 78t(a)) and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder (17 C.F.R. §240.10b‑5) on behalf of all persons other than Defendants who purchased or otherwise acquired Reckitt American Depositary Shares ('ADSs') between January 13, 2021, and July 28, 2024, inclusive (the 'Class Period'), and were damaged thereby (the 'Class'). The Class Action filed by Scott+Scott is captioned: Elevator Constructors Union Local No. 1 Annuity & 401(K) Fund v. Reckitt Benckiser Group PLC, et al., Case No. 1:25-cv-4708. Reckitt is a United Kingdom-based, global consumer goods company. To date, over 500 state and federal products liability lawsuits have been filed against Reckitt and its competitor, Abbott Laboratories ('Abbott'), claiming that they failed to adequately warn that premature infants consuming cow milk-based formulas, such as Reckitt's Enfamil and Abbott's Similac, have an increased risk of developing necrotizing enterocolitis ('NEC'), a life-threatening intestinal disease that affects premature or low birth weight infants. The Class Action alleges that, during the Class Period, Defendants made misleading statements and omissions regarding the Company's business, financial condition, and prospects. Specifically, Defendants failed to warn investors and consumers: (1) that preterm infants were at an increased risk of developing NEC by consuming Reckitt's cow's milk-based formula, Enfamil; (2) of the attendant impact on Reckitt's sales of Enfamil and Reckitt's exposure to legal claims; and (3) as a result of the above, Defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. The market began to learn the truth on March 15, 2024, when, in the case captioned Watson vs. Mead Johnson Co., Case No. 21-L-1032 (Ill. Cir. Ct. Oct. 28, 2021), a jury in St. Clair County, Illinois, returned a $60 million verdict in the first NEC lawsuit to be tried to a verdict. The jury found that Mead Johnson was negligent and failed to warn the decedent's mother of the increased risk her preterm infant could develop NEC by consuming cow's milk-based formula. On this news, the price of the Company's ADSs fell $1.87, or nearly 14%, from a closing price of $13.31 per share on March 14, 2024, to a closing price of $11.44 per share on March 15, 2024. Then, on July 29, 2024, the market continued to learn the truth when, in the case captioned Gill v. Abbot Laboratories, Inc., Case No. 2322-CC1251 (Mo. Circ. Ct. Jun. 23, 2023), a jury in St. Louis, Missouri, concluded that Abbott's specialized formula for premature babies led to a baby developing NEC and awarded the plaintiff $495 million. On this news, the price of the Company's ADSs fell $1.02, or nearly 9%, from a closing price of $11.66 per share on July 28, 2024, to a closing price of $10.64 per share on July 29, 2024. LEAD PLAINTIFF DEADLINE ON AUGUST 4, 2025 If you purchased Reckitt ADSs during the Class Period and were damaged thereby, you are a member of the 'Class' and may be able to seek appointment as lead plaintiff. If you wish to apply to be lead plaintiff, a motion on your behalf must be filed with the U.S. District Court for the Southern District of New York no later than August 4, 2025. The lead plaintiff is a court-appointed representative for absent class members of the Class. You do not need to seek appointment as lead plaintiff to share in any Class recovery in the Class Action. If you are a Class member and there is a recovery for the Class, you can share in that recovery as an absent Class member. If you wish to apply to be lead plaintiff, please contact attorney Nicholas Bruno at (888) 398-9312 or at nbruno@ What Can You Do? You may contact an attorney to discuss your rights regarding the appointment of lead plaintiff or your interest in the Class Action. You may retain counsel of your choice to represent you in the Class Action. About Scott+Scott Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoing, including securities law and shareholder violations. With more than 100 attorneys in eight offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief. Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been repeatedly recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States. To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit This may be considered Attorney Advertising.
Business Upturn
2 days ago
- Business Upturn
Reckitt Partners with Public Health Foundation of India (PHFI) to Drive Transformative Public Health Interventions
New Delhi, Delhi, India: Reckitt, a leading global consumer health and hygiene company, has partnered with the Public Health Foundation of India (PHFI) to strengthen its purpose-led programs across India, with a focus on health, hygiene, sanitation, and life skills education. Established in 2006, PHFI is a globally recognized public-private initiative that has contributed significantly to building India's public health capacity through education, research, and advocacy. The institution was recently ranked second among schools of public health globally (International Journal of Public Health, March 2024) and has been recognized as an ICMR Collaborating Centre of Excellence. The partnership brings together Reckitt's deep experience in driving large-scale behavioural change and PHFI's leadership in public health research, education, and policy. Together, the two organizations aim to co-create innovative solutions, strengthen institutional capacity, and document scalable community health models that can be replicated across India. As part of the collaboration, PHFI will work closely with Reckitt and its civil society partners to validate and document existing outreach programs nationwide. The resulting evidence will be translated into case studies and academic publications to highlight effective, scalable models for health impact. On the partnership, Professor Sanjay Zodpey, President, Public Health Foundation of India (PHFI), said, 'Partnership between Reckitt and Public Health Foundation of India will develop initiatives responding to community health needs for capacity building, training programs and research to address the public health challenges with a focus on sanitation and hygiene.' Ravi Bhatnagar, Director, External Affairs and Partnerships, Reckitt – South Asia, said, 'At Reckitt, we believe we achieve more together as trusted partners. Through collaboration, we can collectively drive systemic, long-term positive change. We deeply value this collaboration, which unites PHFI's academic and policy leadership with Reckitt's on-ground experience in driving behavioural change. Hygiene is the foundation of good health, and this partnership marks another meaningful step in our journey to support the vision of Viksit Bharat by 2047. Trusted, purpose-aligned partnerships like this are essential to building a healthier, more resilient India.' PHFI has established five Indian Institutes of Public Health and contributed more than 4,800 research publications to the field. Its recognition as a global public health leader further showcases the strength it brings to this collaboration to deliver evidence-based health interventions. With this partnership, Reckitt and PHFI are not only setting a new benchmark for public-private collaboration but also laying the groundwork for transformative change in how India addresses its most pressing health challenges. Grounding interventions in science and scaling them through community action, the partnership aims to deliver lasting improvements in sanitation, hygiene, and public health outcomes. More than a partnership, this is a mission-driven alliance focused on shifting narratives, empowering communities, and reinforcing the foundations of India's public health system. Together, Reckitt and PHFI aim to ensure that access to health and hygiene is a right for all, not a privilege. About Reckitt Advertisement Reckitt* exists to protect, heal and nurture in the pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege. Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more. Every day, around 30 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always. We are a diverse global team of 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more or get in touch with us at *Reckitt is the trading name of the Reckitt Benckiser group of companies. Click here for Media Contact Details Submit your press release Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same.
Yahoo
2 days ago
- Yahoo
Reckitt eyes new options to advance Air Wick unit sale, sources say
By Amy-Jo Crowley and Richa Naidu LONDON (Reuters) -Britain's Reckitt is considering new options to advance a sale of its Essential Home business, home to Air Wick fresheners and Cillit Bang cleaners, after bids came in below expectations, two people with knowledge of the process said. The company still plans to pursue a sale, the people said, who spoke on condition of anonymity because the talks are private. Private equity firm Advent remains in talks for the assets, one of the people and a third person said. Reckitt, which also makes Mucinex cold medication and Durex condoms, said in July it was looking to offload a portfolio of homecare brands by the end of 2025. The proposed sale comes at a challenging time for businesses with factories around the world as they navigate U.S. President Donald Trump's tariffs, which are roiling supply chains, boosting costs and dampening shopper sentiment. Reckitt could keep a stake in the business or structure a sale another way to bridge a gap in valuations, one of the people said, adding that some of the bids came in below its hopes of over 4 billion pounds ($5.4 billion). Reuters could not determine if other bidders remained in the process. Reckitt and Advent declined to comment. Bankers and CEOs have hit the brakes on mergers and acquisitions since Trump launched his trade war, with fewer deals getting signed than during the bleakest days of the COVID-19 pandemic and the 2008-2009 global financial crisis. Reckitt said in April that it was "continuing to progress" the sale of the Essential Home business but that market conditions might affect the time frame. Consumer staples companies are considered relatively resilient to economic downturns, but big brands like Reckitt, P&G and Unilever increasingly face competition from cheaper private label brands that gained popularity during the pandemic. Reckitt's Essential Home business has struggled for several quarters, with sales falling 7% in the first quarter of this year to 482 million pounds, about 13% of total revenue for the quarter. Reckitt has been undergoing a turnaround under CEO Kris Licht, who has sought to reassure shareholders concerned about the strength of the company's brands in North America and Europe, where consumer confidence has been dwindling. ($1 = 0.7397 pounds) Sign in to access your portfolio
